Biocept, Inc.
BIOCNASDAQHealthcare
$0.43
+$0.00(+0.00%)
Market Cap$450786
P/E Ratio—
52W High$0.4349
52W Low$0.4349
Biocept, Inc. (BIOC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIOC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $25.86M | $61.25M | $27.46M | $5.53M | $3.25M |
| Cost of Revenue | $28.44M | $37.76M | $21.34M | $10.98M | $10.05M |
| Gross Profit | ($2.58M) | $23.48M | $6.12M | ($5.45M) | ($6.80M) |
| Gross Margin %(computed) | -9.99% | 38.34% | 22.30% | -98.56% | -209.26% |
| Operating Expenses | |||||
| R&D Expenses | $6.16M | $4.96M | $5.22M | $4.70M | $4.47M |
| G&A Expenses | $16.11M | $12.61M | $9.97M | $6.97M | $7.07M |
| Total Operating Expenses | $29.40M | $25.89M | $21.59M | $17.61M | $17.46M |
| Operating Income | ($31.98M) | ($2.41M) | ($15.47M) | ($23.06M) | ($24.26M) |
| Operating Margin %(computed) | -123.69% | -3.93% | -56.33% | -417.05% | -746.35% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.32M | $0.29M | $2.34M | $2.08M | $0.31M |
| Income Before Tax | ($32.21M) | ($2.70M) | ($17.81M) | ($25.14M) | ($24.57M) |
| Income Tax Expense | ($0.13M) | $0.13M | ($0.76M) | ($0.52M) | $0.00M |
| Net Income | ($32.09M) | ($2.82M) | ($17.04M) | ($24.61M) | ($24.57M) |
| Net Margin %(computed) | -124.09% | -4.61% | -62.06% | -445.23% | -755.98% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-56.78 | $-5.73 | $-43.16 | $-357.54 | $-2634.46 |
| Wtd Avg Shares | 0.57M | 0.49M | 0.39M | 0.07M | 0.01M |
| EBITDA | ($30.33M) | ($2.41M) | ($14.47M) | ($23.06M) | ($24.26M) |
| EBITDA Margin %(computed) | -117.29% | -3.93% | -52.68% | -417.05% | -746.35% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Biocept, Inc. data
About Biocept, Inc. (BIOC) Income Statement
Biocept, Inc. (BIOC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, BIOC reported revenue of $0.03B, gross profit of ($0.00B) (gross margin -9.99%), and net income of ($0.03B) — a net profit margin of -124.09%.
Frequently asked questions
BIOC · 4 questionsBiocept, Inc. (BIOC) reported revenue of $0.03B for 2022, down 57.8% year-over-year.
BIOC revenueBIOC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08